VE PHARMA INC. — Erlotinib Importer Profile
Pharmaceutical Importer · #2 buyer for Erlotinib · $185.1K import value · 13 shipments · PHILIPPINES · DGFT Verified
VE PHARMA INC. is the #2 importer of Erlotinib from India with $185.1K in import value and 13 verified shipments. VE PHARMA INC. holds a 6.9% market share in Erlotinib imports based in PHILIPPINES. The company sources from 1 verified supplier across 5 formulations shipped to 1 country. Overall, VE PHARMA INC. imports 4 pharmaceutical products worth $1.9M across 3 therapeutic categories.
VE PHARMA INC. — Erlotinib Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Erlotinib to VE PHARMA INC.?
Verified from 13 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| VEXXA LIFESCIENCES PRIVATE LIMITED | $185.1K | 13 | 100.0% |
VE PHARMA INC. sources Erlotinib from 1 verified Indian supplier based on 13 customs records. The primary supplier is VEXXA LIFESCIENCES PRIVATE LIMITED accounting for 100.0% of imports.
How Does VE PHARMA INC. Compare to Nearest Erlotinib Importers?
Buyers ranked immediately above and below #2 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | VE PHARMA INC. ★ | PHILIPPINES | $185.1K | 13 | $14.2K |
| 3 | VE PHARMA INC ★ | PHILIPPINES | $142.3K | 8 | $17.8K |
| 4 | J. KNIPPER & COMPANY | UNITED STATES | $106.9K | 6 | $17.8K |
VE PHARMA INC. ranks #2 among 144 Erlotinib importers from India. Average shipment value of $14.2K compared to the market average of $8.5K. The closest competitors by value are J. KNIPPER & COMPANY.
Where Does VE PHARMA INC. Import Erlotinib To?
Destination countries from 13 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| PHILIPPINES | $185.1K | 13 | 100.0% |
VE PHARMA INC. imports Erlotinib to 1 country. The primary destination is PHILIPPINES receiving 100.0% of shipments worth $185.1K.
What Erlotinib Formulations Does VE PHARMA INC. Import?
| Formulation | Value | Shipments |
|---|---|---|
| Ervex 150 (ERLOTINIB TABLETS 150 MG) B | $76.9K | 6 |
| Ervex 150 (ERLOTINIB TABLETS 150 MG) | $38.7K | 2 |
| Ervex 150 (ERLOTINIB TABLETS 150 MG) BAT | $38.6K | 3 |
| ERVEX 150 TAB (ERLOTINIB TABLETS 150 MG) | $21.3K | 1 |
| ERVEX 150 (ERLOTINIB TABLETS 150 MG) | $9.5K | 1 |
VE PHARMA INC. imports 5 distinct Erlotinib formulations from India. The top formulation is Ervex 150 (ERLOTINIB TABLETS 150 MG) B with 6 shipments worth $76.9K.
Who Are the Top Buyers of Erlotinib from India and How Much Does VE PHARMA INC. Import?
India exported $1.2M worth of Erlotinib through 336 shipments from 94 suppliers to 55 countries, serving 144 buyers globally. VE PHARMA INC. imports $185.1K of this total, accounting for 6.9% of India's Erlotinib exports with 13 shipments from PHILIPPINES. This is verified from 13 customs shipment records covering 5 distinct formulations.
What Is the Average Order Value for VE PHARMA INC.'s Erlotinib Imports?
VE PHARMA INC.'s average Erlotinib order value is $14.2K per consignment, based on 13 shipments totaling $185.1K. VE PHARMA INC. is based in PHILIPPINES and ranks #2 among all Erlotinib importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Erlotinib to VE PHARMA INC.?
VE PHARMA INC. sources Erlotinib from 1 verified Indian supplier: VEXXA LIFESCIENCES PRIVATE LIMITED ($185.1K, 100.0%). This is based on 13 customs records.
How Does VE PHARMA INC. Compare to Other Erlotinib Importers?
VE PHARMA INC. ranks #2 among 144 Erlotinib importers from India with a 6.9% market share. The top 3 importers are VE PHARMA INC. ($185.1K), VE PHARMA INC ($142.3K), J. KNIPPER & COMPANY ($106.9K). VE PHARMA INC. processed 13 shipments from PHILIPPINES.
What Other Advanced Oncology Products Does VE PHARMA INC. Import?
VE PHARMA INC. also imports these advanced oncology products. Each links to the detailed product page.
About VE PHARMA INC.
VE PHARMA INC. imports 4 products worth $1.9M. Beyond Erlotinib, top products include Docetaxel, Imipenem, Gefitinib. View the complete VE PHARMA INC. profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Erlotinib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Erlotinib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: VE PHARMA INC. matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as VE PHARMA INC.'s capped import value divided by total capped export value for Erlotinib across all Indian exporters.
- 5.Verified Records: This page is backed by 13 individual customs records matching VE PHARMA INC. importing Erlotinib, covering 5 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 55+ countries, 144+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Erlotinib Import Data for VE PHARMA INC.
Access order-level details, pricing data, supplier connections, and competitive analysis for VE PHARMA INC.'s Erlotinib imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
VE PHARMA INC.
Full Company Profile →
4 products · $1.9M total trade · 3 categories
VE PHARMA INC. × Erlotinib
Verified from customs records
Company Overview
Top Products by VE PHARMA INC.
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for VE PHARMA INC..
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Erlotinib. For current order-level data, contact TransData Nexus.